These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 21998286)

  • 1. Characterization of human immunodeficiency virus type 1 (HIV-1) diversity and tropism in 145 patients with primary HIV-1 infection.
    Rieder P; Joos B; Scherrer AU; Kuster H; Braun D; Grube C; Niederöst B; Leemann C; Gianella S; Metzner KJ; Böni J; Weber R; Günthard HF
    Clin Infect Dis; 2011 Dec; 53(12):1271-9. PubMed ID: 21998286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences in molecular evolution between switch (R5 to R5X4/X4-tropic) and non-switch (R5-tropic only) HIV-1 populations during infection.
    Mild M; Kvist A; Esbjörnsson J; Karlsson I; Fenyö EM; Medstrand P
    Infect Genet Evol; 2010 Apr; 10(3):356-64. PubMed ID: 19446658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemokine (C-C motif) receptor 5-using envelopes predominate in dual/mixed-tropic HIV from the plasma of drug-naive individuals.
    Irlbeck DM; Amrine-Madsen H; Kitrinos KM; Labranche CC; Demarest JF
    AIDS; 2008 Jul; 22(12):1425-31. PubMed ID: 18614865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of genotypic prediction of HIV-1 tropism using population sequencing of replicates.
    Ferreira JL; Coelho LP; Rodrigues R; Cabral GB; Cavalcanti Jde S; Guimaraes PM; Brigido LF
    J Virol Methods; 2012 Feb; 179(2):325-9. PubMed ID: 22138669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High frequency of X4/DM-tropic viruses in PBMC samples from patients with primary HIV-1 subtype-B infection in 1996-2007: the French ANRS CO06 PRIMO Cohort Study.
    Frange P; Galimand J; Goujard C; Deveau C; Ghosn J; Rouzioux C; Meyer L; Chaix ML
    J Antimicrob Chemother; 2009 Jul; 64(1):135-41. PubMed ID: 19411680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sexually-transmitted/founder HIV-1 cannot be directly predicted from plasma or PBMC-derived viral quasispecies in the transmitting partner.
    Frange P; Meyer L; Jung M; Goujard C; Zucman D; Abel S; Hochedez P; Gousset M; Gascuel O; Rouzioux C; Chaix ML;
    PLoS One; 2013; 8(7):e69144. PubMed ID: 23874894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular determinants of HIV-2 R5-X4 tropism in the V3 loop: development of a new genotypic tool.
    Visseaux B; Hurtado-Nedelec M; Charpentier C; Collin G; Storto A; Matheron S; Larrouy L; Damond F; Brun-Vézinet F; Descamps D;
    J Infect Dis; 2012 Jan; 205(1):111-20. PubMed ID: 22140264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of HIV-1 CXCR4 tropism and resistance in treatment experienced subjects receiving CCR5 antagonist-Vicriviroc.
    McNicholas P; Vilchez RA; Greaves W; Kumar S; Onyebuchi C; Black T; Strizki JM
    J Clin Virol; 2012 Oct; 55(2):134-9. PubMed ID: 22824230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Co-receptor switch during HAART is independent of virological success.
    Saracino A; Monno L; Cibelli DC; Punzi G; Brindicci G; Ladisa N; Tartaglia A; Lagioia A; Angarano G
    J Med Virol; 2009 Dec; 81(12):2036-44. PubMed ID: 19856465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Greater diversity of HIV DNA variants in the rectum compared to variants in the blood in patients without HAART.
    Avettand-Fenoel V; Hocqueloux L; Müller-Trutwin M; Prazuck T; Melard A; Chaix ML; Agoute E; Michau C; Rouzioux C
    J Med Virol; 2011 Sep; 83(9):1499-507. PubMed ID: 21739438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV-1 chemokine coreceptor utilization in paired cerebrospinal fluid and plasma samples: a survey of subjects with viremia.
    Spudich SS; Huang W; Nilsson AC; Petropoulos CJ; Liegler TJ; Whitcomb JM; Price RW
    J Infect Dis; 2005 Mar; 191(6):890-8. PubMed ID: 15717264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors associated with proviral DNA HIV-1 tropism in antiretroviral therapy-treated patients with fully suppressed plasma HIV viral load: implications for the clinical use of CCR5 antagonists.
    Soulié C; Fourati S; Lambert-Niclot S; Malet I; Wirden M; Tubiana R; Valantin MA; Katlama C; Calvez V; Marcelin AG
    J Antimicrob Chemother; 2010 Apr; 65(4):749-51. PubMed ID: 20150182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential impact of viral load and genetic makeup of HIV type 1 on mother-to-child transmission: characterization of env-C2V3C3 and nef sequences.
    Pádua E; Parreira R; Tendeiro R; Nunes B; Castela J; Soares I; Mouzinho A; Reis E; Paixão MT
    AIDS Res Hum Retroviruses; 2009 Nov; 25(11):1171-7. PubMed ID: 19886833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A substantial transmission bottleneck among newly and recently HIV-1-infected injection drug users in St Petersburg, Russia.
    Masharsky AE; Dukhovlinova EN; Verevochkin SV; Toussova OV; Skochilov RV; Anderson JA; Hoffman I; Cohen MS; Swanstrom R; Kozlov AP
    J Infect Dis; 2010 Jun; 201(11):1697-702. PubMed ID: 20423223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV-2 A-subtype gp125c₂-v₃-c₃ mutations and their association with CCR5 and CXCR4 tropism.
    Dimonte S; Svicher V; Salpini R; Ceccherini-Silberstein F; Perno CF; Babakir-Mina M
    Arch Virol; 2011 Nov; 156(11):1943-51. PubMed ID: 21814863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genotypic analysis of human immunodeficiency virus type 1 env V3 loop sequences: bioinformatics prediction of coreceptor usage among 28 infected mother-infant pairs in a drug-naive population.
    Duri K; Soko W; Gumbo F; Kristiansen K; Mapingure M; Stray-Pedersen B; Muller F;
    AIDS Res Hum Retroviruses; 2011 Apr; 27(4):411-9. PubMed ID: 20969460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. First transmission of human immunodeficiency virus Type 1 by a cellular blood product after mandatory nucleic acid screening in Germany.
    Schmidt M; Korn K; Nübling CM; Chudy M; Kress J; Horst HA; Geusendam G; Hennig H; Sireis W; Rabenau HF; Doerr HW; Berger A; Hourfar MK; Gubbe K; Karl A; Fickenscher H; Tischer BK; Babiel R; Seifried E; Gürtler L
    Transfusion; 2009 Sep; 49(9):1836-44. PubMed ID: 19453990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evolution of HIV-1 quasispecies and coreceptor use in cell reservoirs of patients on suppressive antiretroviral therapy.
    Raymond S; Saliou A; Delobel P; Cazabat M; Pasquier C; Jeanne N; Sauné K; Massip P; Marchou B; Izopet J
    J Antimicrob Chemother; 2014 Sep; 69(9):2527-30. PubMed ID: 24840625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of HIV tropism on decreases in CD4 cell count, clinical progression, and subsequent response to a first antiretroviral therapy regimen.
    Waters L; Mandalia S; Randell P; Wildfire A; Gazzard B; Moyle G
    Clin Infect Dis; 2008 May; 46(10):1617-23. PubMed ID: 18419499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural evolution of CD4+ cell count in patients with CD4 >350 or >500  cells/mm3 at the time of diagnosis according to HIV-1 coreceptor tropism.
    Soulié C; Charpentier C; Flandre P; Nino C; Carcelain G; Simon A; Katlama C; Landman R; Brun-Vézinet F; Descamps D; Calvez V; Marcelin AG
    J Med Virol; 2012 Dec; 84(12):1853-6. PubMed ID: 23080487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.